Source: Annual Congress 2005 - Cystic fibrosis lung disease: let's make things better
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. Laki, K. Nemeth, I. Laki, R. Ujhelyi, O. Bede, E. Endreffy, K. Gyurkovits, K. Bolbas, E. Solyom, E. Csiszer, A. Halasz, G. Dobra, I. Karadi, L. Romics, G. Fekete, G. Fust (Budapest, Hungary). 8.1 ancestral haplotype (AH) protects against colonization in cystic fibrosis (CF). Eur Respir J 2005; 26: Suppl. 49, 4625

Member's Comments

No comment yet.

Related content which might interest you: TGFβ1 genotype in correlation to TGFβ1 induced sputum (IS) and serum in cystic fibrosis (CF) Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011 Pseudomonas aeruginosa (Pa) antibiotic resistance (AR): Comparison in adults and children with cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Monitoring small airways disease (SAD) in cystic fibrosis (CF) Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases Year: 2011 Relationship between nasal potential difference (NPD) and respiratory function in cystic fibrosis (CF) patients Source: Eur Respir J 2001; 18: Suppl. 33, 125s Year: 2001 The impact of colonization with therapy-resistant pathogens on the survival rate after lung transplantation (LUTX) in cystic fibrosis (CF) Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward? Year: 2021 The impact of genotype on clinical course of cystic fibrosis (CF) in adult patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Repeat polymorphisms (pol.) in the NOS-1 gene and its association with the clinical severity of cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010 Evolution of the infectious disease in cystic fibrosis (CF) Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases Year: 2008 Azithromycin (AZM) regulates glutathione-S-transferases (GST)s in cystic fibrosis (CF) airway cells Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008 Early re-colonization with pseudomonas aeruginosa (PA) after treatment: a possible risk factor for development of chronic infection in cystic fibrosis (CF) patients Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008 Association of FCN1 and FCN2 gene polymorphisms with earlier onset of chronic pseudomonas aeruginosa (Pa) colonisation in cystic fibrosis (CF) patients Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation Year: 2011 Bacterial biofilms in bronchiectasis of primary ciliary dyskinesia (PCD) in comparison with cystic fibrosis (CF) Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012 Effect of recurrent growth of aspergillus on lung function in paediatric population with cystic fibrosis (CF) Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011 Effect of prior year pulmonary exacerbation (PE) frequency on response to ARD-3150 in patients with non-cystic fibrosis bronchiectasis (NCFB) chronically infected with Pseudomonas aeruginosa (PA) Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018 Function of ciliary epithelium in the patients with cystic fibrosis (CF) with chronic Ps.aeruginosa infection and without Ps.aeruginosa Source: Eur Respir J 2001; 18: Suppl. 33, 125s Year: 2001 Dual release ciprofloxacin for inhalation (DRCFI) reduces sputum pseudomonas aeruginosa (Pa) density and delays time to infective pulmonary exacerbation in non-cystic fibrosis (CF) bronchiectasis (BE) Source: Annual Congress 2011 - Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis Year: 2011 Phenotypic characteristics in adult cystic fibrosis (CF) patients carrying 3849+10kbC>T mutation in Russia Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015 Nasal potential difference (NPD) in cystic fibrosis (CF) and non-CF patients with borderline sweat test Source: Eur Respir J 2001; 18: Suppl. 33, 215s Year: 2001 Lung function and early abnormality of glucose tolerance (GT) in cystic fibrosis (CF) patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Hyperinflation in adult cystic fibrosis (CF) patients: Clinical and functional correlates Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010